Low-cost drug discovery with engineered E. coli reveals an anti-mycobacterial activity of benazepril
Nadine Bongaerts, Zainab Edoo, Ayan A. Abukar, Xiaohu Song, Sebastián Sosa-Carrillo, Ariel B. Lindner, Edwin H. Wintermute
The paper uses engineered E. coli to screen for Mtb inhibitors, identifying benazepril as an anti-mycobacterial drug with a novel mechanism.
bioRxiv · Mar 26, 2021 · PreprintSynthetic Biology